These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 22394602)

  • 1. Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis.
    Hudson M; Pope J; Mahler M; Tatibouet S; Steele R; Baron M; ; Fritzler MJ
    Arthritis Res Ther; 2012 Mar; 14(2):R50. PubMed ID: 22394602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival.
    Wodkowski M; Hudson M; Proudman S; Walker J; Stevens W; Nikpour M; Assassi S; Mayes MD; Wang M; Baron M; Fritzler MJ; ; ;
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S131-5. PubMed ID: 26315678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis.
    Martel ME; Leurs A; Launay D; Behal H; Chepy A; Collet A; Sanges S; Hachulla E; Dubucquoi S; Dauchet L; Sobanski V
    Autoimmun Rev; 2024 May; 23(5):103536. PubMed ID: 38555075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of an association between anti-Ro antibodies and prolonged QTc interval in systemic sclerosis: a multicenter study of 689 patients.
    Massie C; Hudson M; Tatibouet S; Steele R; Huynh T; Fritzler MJ; Baron M; Pineau CA;
    Semin Arthritis Rheum; 2014 Dec; 44(3):338-44. PubMed ID: 25128430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients.
    Lee A; Patterson KA; Tan DJ; Wilson ME; Proudman SM; Stevens W; Nikpour M; Sahhar J; Ngian GS; Roddy J; Roberts-Thomson PJ; Walker JG
    Scand J Rheumatol; 2021 Nov; 50(6):469-474. PubMed ID: 33851896
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-SSA/Ro52 autoantibodies in scleroderma: results of an observational, cross-sectional study.
    Sánchez-Montalvá A; Fernández-Luque A; Simeón CP; Fonollosa-Plà V; Marín A; Guillén A; Vilardell M
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-177-82. PubMed ID: 25372801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodies.
    Gkoutzourelas A; Liaskos C; Simopoulou T; Katsiari C; Efthymiou G; Scheper T; Meyer W; Tsirogianni A; Tsigalou C; Dardiotis E; Daoussis D; Sakkas LI; Bogdanos DP
    Rheumatol Int; 2020 Oct; 40(10):1689-1699. PubMed ID: 32681396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies.
    Frank MB; McCubbin V; Trieu E; Wu Y; Isenberg DA; Targoff IN
    J Autoimmun; 1999 Mar; 12(2):137-42. PubMed ID: 10047434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests.
    Mahler M; Satoh M; Hudson M; Baron M; Chan JY; Chan EK; Wick J; Fritzler MJ;
    J Rheumatol; 2014 Jul; 41(7):1334-43. PubMed ID: 24931955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
    Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
    Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis.
    Gkoutzourelas A; Liaskos C; Mytilinaiou MG; Simopoulou T; Katsiari C; Tsirogianni A; Daoussis D; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
    Front Immunol; 2018; 9():2835. PubMed ID: 30581434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study.
    Ghillani P; André C; Toly C; Rouquette AM; Bengoufa D; Nicaise P; Goulvestre C; Gleizes A; Dragon-Durey MA; Alyanakian MA; Chretien P; Chollet-Martin S; Musset L; Weill B; Johanet C
    Autoimmun Rev; 2011 Jul; 10(9):509-13. PubMed ID: 21447407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity.
    Lee AYS
    Rheumatol Int; 2017 Aug; 37(8):1323-1333. PubMed ID: 28417151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients.
    D'Aoust J; Hudson M; Tatibouet S; Wick J; ; Mahler M; Baron M; Fritzler MJ
    Arthritis Rheumatol; 2014 Jun; 66(6):1608-15. PubMed ID: 24577935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study.
    Hamberg V; Sohrabian A; Volkmann ER; Wildt M; Löfdahl A; Wuttge DM; Hesselstrand R; Dellgren G; Westergren-Thorsson G; Rönnelid J; Andréasson K
    Arthritis Res Ther; 2023 Sep; 25(1):162. PubMed ID: 37667402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies: Diagnostic utility of their separate detection.
    Menéndez A; Gómez J; Escanlar E; Caminal-Montero L; Mozo L
    Autoimmunity; 2013 Feb; 46(1):32-9. PubMed ID: 23039326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and serological evaluation of a novel CENP-A peptide based ELISA.
    Mahler M; Maes L; Blockmans D; Westhovens R; Bossuyt X; Riemekasten G; Schneider S; Hiepe F; Swart A; Gürtler I; Egerer K; Fooke M; Fritzler MJ
    Arthritis Res Ther; 2010; 12(3):R99. PubMed ID: 20487535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Ro52/TRIM21 antibodies are associated with aberrant inflammatory circuits in patients with systemic autoimmune rheumatic diseases.
    Amezcua-Guerra LM; Pérez-García LF; Jiménez-Rojas V; Márquez-Velasco R; Silveira LH
    Gac Med Mex; 2023; 159(1):55-64. PubMed ID: 36930561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases.
    Robbins A; Hentzien M; Toquet S; Didier K; Servettaz A; Pham BN; Giusti D
    Front Immunol; 2019; 10():444. PubMed ID: 30915082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological profile of patients with systemic sclerosis.
    Wielosz E; Dryglewska M; Majdan M
    Postepy Hig Med Dosw (Online); 2014 Aug; 68():987-91. PubMed ID: 25228505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.